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Background and aims: Corticostriatal-limbic neurocircuitry, emotional and motivational processing, dopaminergic
and noradrenergic systems and genetic factors have all been implicated in pathological gambling (PG). However,
allelic variants of genes inﬂuencing dopaminergic and noradrenergic neurotransmitters have not been investigated
with respect to the neural correlates of emotional and motivational states in PG. Dopamine beta-hydroxylase
(DBH) converts dopamine to norepinephrine; the T allele of a functional single-nucleotide polymorphism
rs1611115 (C-1021T) in the DBH gene is associated with less DBH activity and has been linked to emotional
processes and addiction. Here, we investigate the inﬂuence of rs1611115 on the neural correlates of emotional
and motivational processing in PG and healthy comparison (HC) participants. Methods: While undergoing
functional magnetic resonance imaging, 18 PG and 25 HC participants, all European Americans, viewed gambling-,
sad-, and cocaine-related videotapes. Analyses focused on brain activation differences related to DBH genotype
(CC/T-carrier [i.e., CT and TT]) and condition (sad/gambling/cocaine). Results: CC participants demonstrated greater
recruitment of corticostriatal-limbic regions, relative to T-carriers. DBH variants were also associated with altered
corticostriatal-limbic activations across the different videotape conditions, and this association appeared to be driven
by greater activation in CC participants relative to T-carriers during the sad condition. CC relative to T-carrier
subjects also reported greater subjective sadness to the sad videotapes. Conclusions: Individual differences in genetic
composition linked to aminergic function contribute signiﬁcantly to emotional regulation across diagnostic groups
and warrant further investigation in PG.
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INTRODUCTION
Pathological gambling (PG; gambling disorder in DSM-5)
has an estimated heritability of 50%–66% (Xian, Giddens,
Scherrer, Eisen, & Potenza, 2014). Most reported genetic
studies of PG are limited to very small-scale (in terms of a
genetic association design for complex traits) candidate-
gene approaches (N= 68 to 186 PGs) for candidate genes
involving mainly in dopaminergic and serotonergic systems
with weak or inconsistent effects (Gyollai et al., 2014). The
ﬁrst large-scale genome-wide association study (GWAS) on
a PG-related trait (Lind et al., 2013) identiﬁed no gene
variants reaching genome-wide signiﬁcance. However,
larger effect sizes may be observed in regard to functional
variants of enzyme-encoding genes; these may relate to
brain activations and treatment outcome in PG (Grant
et al., 2013).
Both dopamine and norepinephrine alterations have been
implicated in PG (Boileau et al., 2014; Linnet et al., 2012).
The DBH gene variant, which regulates the enzyme DBH’s
conversion of dopamine to norepinephrine, is linked with
various addiction and impulsive phenotypes (Cubells et al.,
2000; Hess et al., 2009). In European Americans (EAs), the
functional promoter variant in DBH, single-nucleotide poly-
morphism (SNP) rs1611115, is associated with 35%–52%
of the variance in plasma DBH activity; in a dosage-effect
fashion, the TT genotype is associated with the lowest DBH
plasma activity, followed by CT demonstrating intermediary
activity, and CC showing the greatest levels of enzymatic
function (Zabetian et al., 2001). These genotypes are further
associated with alterations in emotional/motivational pro-
cessing; for example, T-carriers demonstrate diminished
empathic ability relative to CC genotypes (Gong, Liu, Li, &
Zhou, 2014). The TT genotype (relative to CC or CT) is also
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associated with higher neuroticism and novelty seeking but
lower conscientiousness, suggestive of an impulsive per-
sonality style (Hess et al., 2009). The TT genotype is also
associated with increased severity of heroin use (Xie et al.,
2013) and poorer cocaine treatment outcomes (Kosten et al.,
2013). Moreover, drugs affecting DBH activity, such as
disulﬁram, demonstrate promise in treatment of substance
and non-substance addictions (Carroll et al., 2004; Kosten
et al., 2013; Muller, Banas, Heinz, & Hein, 2011; Skinner,
Lahmek, Pham, & Aubin, 2014).
The current study used functional magnetic resonance
imaging (fMRI) to investigate effects of DBH polymorph-
isms on emotional/motivational processing. Given the
infrequency of TT homozygotes and prior studies
highlighting the clinical relevance of T-carrier status, we
investigated T-carriers and those with CC genotypes. Both
PG and healthy comparison (HC) participants were
scanned while watching videos designed to elicit sad
feelings, gambling urges, or cocaine cravings (Kober
et al., 2016; Potenza et al., 2003; Wexler et al., 2001).
Sad, gambling, and cocaine videos were studied with the
following rationale and goals. Experiential sadness has
been linked to changes in dopaminergic and noradrenergic
function (Harmer, Perrett, Cowen, & Goodwin, 2001;
Peron, Grandjean, Drapier, & Verin, 2014), and the DBH
polymorphism is associated with empathic responses
(Gong et al., 2014). As some investigators have considered
PG within an affective framework (Grant, 2004), PG has
been associated with negative affective states and mood
disorders (Potenza, Xian, Shah, Scherrer, & Eisen, 2005)
and prior ﬁndings using the same task have identiﬁed
alterations in the neural correlates of sad states in PG
subjects (Kober et al., 2016; Potenza et al., 2003), sad
videos were included in this study. Finally, the cocaine
videos served as an active control condition to identify
speciﬁcity of neural responses to the gambling (a main
focus of the study) and sad videos; previous evidence
demonstrates that the cocaine videos elicit emotional
responses in people with and without cocaine dependence
(CD; Wexler et al., 2001).
Recently, we reported on data from this sample (Kober
et al., 2016). In this study, we restricted the sample to EA
subjects given the genetic focus and thus focused on PG
and HC to have sufﬁcient samples for each group. We also
focused on sustained emotional/motivational responses as
we have done previously (Potenza, 2008). We hypothe-
sized observing main effects of DBH genotype on corti-
colimbic activations and interactions with condition and
DBH genotype. For DBH-genotype-by-condition interac-
tion effects, we hypothesized that T-carriers would report
less sadness to sad videos, in line with reports of reduced
empathic responses in these individuals (Gong et al.,
2014); further, we hypothesized that the neural expression
of this effect would be reﬂected in diminished corticos-
triatal recruitment in T-carriers relative to the CC group
during sad videos. Based on prior ﬁndings (Potenza,
2008; Potenza et al., 2003), we also expected group-
by-condition interaction effects involving diminished
ventromedial prefrontal cortex (vmPFC) and ventral stri-
atum (VS) activity in the PG group during gambling
videos.
METHODS AND MATERIALS
Participants
EA subjects, who provided fMRI and genetic data, were
included from a larger sample of multi-ethnic individuals,
whose data are reported elsewhere (Kober et al., 2016). To
avoid potential genetic population stratiﬁcation, only EA
individuals were included: 18 individuals meeting PG cri-
teria and 25 HC subjects. All subjects were native English
speakers with no history of neurologic disorders or injury. A
structured clinical interview (First, 1997) determined that
PG subjects met DSM-IV criteria for PG as the primary
diagnosis and that HC subjects had no axis-I disorders
except possible nicotine dependence (ND; one ND subject
in the HC group). Detailed participant characteristics in-
cluding PG comorbidity with other psychiatric disorders are
described in Supplementary Material I, with demographic
information provided in Table 1 (including information on
use of the Barratt impulsiveness scale (BIS-11) and
South Oaks Gambling Screen (SOGS) and Supplementary
Material II).
Genotyping
DNA was extracted from whole blood. The SNP rs1611115
was genotyped for all subjects by a ﬂuorogenic 5’ nuclease
assay of the TaqMan method using the ABI PRISM 7900
Sequence Detection System (ABI, Foster City, CA). No
discrepancy was detected between the duplicates for one PG
subject, one HC subject, and one control Centre d’Etude
du Polymorphisme Humain (representative of the EA pop-
ulation) in the quality control of genotyping procedures.
Genotypes were in Hardy–Weinberg equilibrium for the PG,
HC, and combined PG and HC groups (all p> .05).
Experimental task
Participants viewed six videos in random and counterba-
lanced order (see Supplementary Material III), including
two videos each related to gambling, sad and cocaine
scenarios in which actors depict each speciﬁc scenario. The
detailed scenarios are previously described (Kober et al.,
2016; Potenza et al., 2003; Wexler et al., 2001), with further
descriptions in Supplementary Material IV. Subjective
responses to videos were recorded on a scale of 0–10 and
involved rating emotional intensity, gambling urges, and
drug cravings (Potenza et al., 2003; Wexler et al., 2001).
Image acquisition
Images were obtained using a 3-T Siemens Trio MRI system
equipped with a standard quadrature head coil, using T2*-
sensitive gradient-recalled single-shot echo-planar pulse
sequence. Subjects were positioned in the coil and head
movements were restrained using foam pillows. Anatomical
images at the functional slice locations were next obtained
with spin-echo imaging in the axial plane parallel to the
anterior-commissure/posterior-commissure (AC–PC) line
with repetition time (TR) = 300 ms, echo time (TE)=
2.47 ms, bandwidth = 300 Hz/pixel, ﬂip angle (FA)= 60°,
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ﬁeld of view = 220 × 220 mm, matrix = 256 × 256,
25 slices with slice thickness= 5 mm and no gap. Functional
blood-oxygen-level-dependent (BOLD) signals were then
acquired with a single-shot gradient echo-planar-imaging
sequence. Twenty-ﬁve axial slices parallel to the AC–PC
line covering the whole brain were acquired with TR=
1500 ms, TE= 27 ms, bandwidth = 2520 Hz/pixel, FA =
60°, ﬁeld of view= 220 × 220 mm, matrix = 64 × 64,
25 slices with slice thickness = 5 mm and no gap. Six fMRI
runs (two per condition) were acquired. Following func-
tional imaging, high-resolution 3-DMagnetization-Prepared
Rapid-Gradient Echo (MPRAGE) data (TR= 2530 ms;
TE= 3.34 ms; bandwidth = 180 Hz/pixel; FA = 7°; slice
thickness = 1 mm; ﬁeld of view= 256 × 256 mm; matrix =
256 × 256) were acquired for multi-subject registration.
Data analysis
Data were converted from Digital Imaging and Communi-
cation in Medicine (DICOM) format to ANALYZE format
using XMedCon (Nolf, 2003). The ﬁrst six volumes of each
functional series were discarded to enable signal to achieve
steady-state equilibrium. Functional images were ﬁrst slice-
time-corrected and then realigned (motion corrected) with
the Statistical Parametric Mapping 5 algorithm (www.ﬁl.
ion.ucl.ac.uk/spm/software/spm5) for three translational
directions (x, y, or z) and three possible rotations (pitch,
yaw, or roll). Trials with linear motion that had a displace-
ment in excess of 2 mm or rotation in excess of 3° were
rejected. Corrected images were spatially smoothed by
using a Gaussian ﬁlter with a full-width-at-half-maximum of
6.876 mm. Analysis-of-covariance (ANCOVA) approaches
as described below controlled for covariates and analyzed
signal change during the entire period of video-viewing
relative to the combined pre- and post-baseline (see
Supplementary Material X). Post hoc t-test comparisons
were implemented to dissect what drived the effects identi-
ﬁed in the ANCOVAs and examined the nature of the
effects. For subjective-response data, analyses of variance
(ANOVAs) tested emotional/motivational ratings between
the PG and HC groups. ANOVAs tested DBH genotype
differences for the sad condition.
Analysis-of-covariance
Data were converted to AFNI format (http://afni.nimh.nih.
gov) for ANCOVAs. We applied a 2 × 2 × 3 ANCOVA
with age adjustment involving two DBH genotypic groups
(CC/T-carrier), two diagnostic groups (PG/HC), and three
conditions (gambling, sad, and cocaine), in which subject
was treated as a random factor using the GroupAna program
from the AFNI MATLAB library (http://afni.nimh.nih.
gov/afni/matlab/). Results were masked, converted back to
ANALYZE format and viewed in Yale BioImage Suite
(http://wwww.bioimagesuite.org). Data were thresholded at
a voxel level of p< .05, corrected for multiple comparisons
by spatial extent of contiguous suprathresholded individual
voxels at a family-wise-error-corrected (FWE corrected)
threshold of p< .05. In a Monte-Carlo simulation using
AFNI (applying a smoothing kernel of 6.876 mm and a
connection radius of 6.97 mm on 3.44 mm × 3.44 mm ×
5 mm voxels), an activation volume of 311 voxels (8402 μl)
satisﬁed the FWE-corrected p< .05 threshold.
Ethics
The investigation was carried out in accordance with the
latest version of the Declaration of Helsinki; the protocol
was approved by the Yale Human Investigation Committee.
All subjects were recruited through advertisements and
provided written informed consent after the nature of the
procedures had been fully explained.
Table 1. Subject characteristics
(A) PG HC p-value
Sample size 18 25
Sex, male (%) 13 (72.2%) 15 (60.0%) .613
Age (mean ± SD) 36.6 ± 12.0 30.0 ± 11.4 .079
Education years 13.8 ± 1.8 14.6 ± 2.2 .242
FTND 1.7 ± 2.8 .1 ± .6 .038*
South Oaks Gambling Screen Score 12.5 ± 3.5 .08 ± .3 2.1 × 10−11*
BIS-11 total score 71.7 ± 13.6 54.6 ± 8.4 7.5 × 10−5*
CC T-carrier
(B) DBH genotype Count (%) Count (%) Total p-value
PG 9 (50.0) 9 (50.0) 18 .937
HC 11 (44.0) 14 (56.0) 25
Male 13 (46.4) 15 (53.6) 28 ∼1
Female 7 (46.7) 8 (53.3) 15
BIS-11 total score 58.3 ± 9.6 65.3 ± 16.2 .093
Sad video–Emotional intensity 6.88 ± 1.7 5.52 ± 2.3 .035*
Note. BIS-11, Barratt impulsiveness scale, version 11; FTND, Fagerstrom test for nicotine dependence; PG, pathological gambling; HC,
healthy comparison.
*p< .05.
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RESULTS
Diagnostic group differences
The PG group (versus HC group) was more impulsive (p=
7.5 × 10−5) and demonstrated greater problem-gambling
severity on the SOGS (p= 2.1 × 10−11).
Genotype distribution
No between-group differences in genotypic distributions of
SNP rs1611115 were observed between PG and HC subjects
(p> .05) or between male and female subjects (p> .05)
(Table 1B). Modestly higher impulsivity scores in T-carriers
relative to CC individuals did not reach signiﬁcance
(p= .093).
Brain activations elicited by videos
Signiﬁcant two-way interaction effects emerged for DBH-
genotype-by-condition (Figure 1A) and group-by-condition
(Figure 1C) analyses (see Supplementary Material VI for
additional activation maps). No activations in group-by-
DBH-genotype and group-by-DBH-genotype-by-condition
interactions survived whole-brain correction. Main effects
of DBH genotype and condition on brain activation were
identiﬁed; main effects of group did not survive whole-brain
correction. Extracted BOLD-signal changes from the iden-
tiﬁed regions were used to understand the nature of the
signiﬁcant effects, as described below.
DBH-genotype-by-condition interaction
A DBH-genotype-by-condition interaction identiﬁed one
cluster involving the bilateral thalamus and putamen extend-
ing to the left insula, hippocampus, caudate, dorsolateral
prefrontal cortex (dlPFC), and anterior cingulate cortex
(ACC) (Figure 1A and B; Cluster-a). Another cluster in-
volved the right dlPFC and posterior cingulate cortex
(Figure 1A and B; Cluster-b; Table 2C). For both clusters,
signiﬁcant differences appear driven by greater activation in
theDBH CC participants relative to T-carriers during the sad
Figure 1. Activation maps displaying interactive effects of DBH genotype, condition and diagnostic group. The axial brain sections
highlighting regions showing signiﬁcant two-way interactions adjusted by age involving two genotypic groups (CC, T-carrier [shown as
Tx]), two diagnostic groups (pathological gambling, healthy comparison, shortened as PG and HC, respectively) and three cue conditions
(gambling, sad, and cocaine, shortened as Gam, Sad, and Coc, respectively) are shown. The maps are thresholded at p< .05, with a family-
wise-error correction. Talairach z levels are indicated (A, C). The bar on the right side of the Figures A and C indicates the strengths of
identiﬁed interactions. Right side of the brain is shown on the left. Indicated on the right (B and D) are extracted values of percentage signal
changes according to respective interactions for genotype (CC, T-carrier [shown as Tx]), diagnostic group (PG, HC) or condition (gam, sad,
and coc). Outliers of BOLD-signal are marked by circles; outlier evaluation by exclusion and retest; all the effects in the retests remained
similar. mOFC=medial orbitofrontal cortex; vPFC= ventral prefrontal cortex. Cluster-a: Thalamus/putamen/caudate/insula/dorsal
lateralprefrontal cortex/hippocampus/anterior cingulate/pars triangularis/superior temporal gyrus/primary sensory/primary motor. Cluster-b:
Frontal eye ﬁelds/dorsolateral prefrontal cortex/posterior cingulate
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Table 2. Age-adjusted main and interactive effects of DBH genotype, condition and diagnostic group on regional brain activations
Left/
Right
Volume mm3
(voxels)
Talairach
CenterMass
(x, y, z)
F-values
Mean
F-values
Stdev
(A) Main effect DBH genotype
Cerebellum_parahippocampus_hippocampus_fusiform 35375 (1310) −9, −56, −22 5.85 1.56
Ventral striatum_orbital frontal cortex_anterior
cingulate_rostrolateral prefrontal
Cortex_I nferior frontal gyrus_amygdala 19055 (706) −8, 20, −6 5.96 1.72
Subclusters: Ventral striatum L 955 (35) −13, 0, −5 6.45 2.21
Anterior cingulate L/R 2301 (85) 3, 32, 0 5.09 .88
Amygdala L 500 (19) −17, −7, −10 6.04 1.48
Caudate L 774 (29) −12, 14, 0 5.63 1.22
Putamen L 525 (19) −21, 7, −4 5.67 1.65
vmPFC L/R 5146 (191) −8, 13, −15 6.72 2.19
(B) Main effect condition
Occipital cortex_temporal gyrus_angular gyrus_fusiform
gyrus_temporopolar area_thalamus_posteror
cingulate_cerebellum
249810 (9252) −1, −52, 4 9.00 6.52
Subclusters: Thalamus L 2089 (77) −11, −23, 3 4.18 .83
Thalamus R 563 (21) 7, −23, 2 3.76 .48
Posterior cingulate L/R 4181 (155) −8, −55, 33 4.82 1.37
Anterior cingulate cortex_anterior prefrontal
cortex_orbitofrontal gyri_I nsula
12983 (481) −9, 42, −6 4.39 1.18
Subclusters: Insula L 232 (9) −26, 20, 0 3.66 .40
vmPFC L/R 4151 (154) −8, 37, −20 4.18 1.03
Anterior cingulate L/R 1402 (52) −4, 39, 8 4.58 1.29
Medial frontal gyrus L/R 5907 (219) −8, 48, −4 4.57 1.27
(C) DBH genotype X condition
Thalamus_putamen_caudate_I nsula_dlPFC_
Hippocampus_anterior cingulate_pars
triangularis_superior temporal gyrus_primary
56708 (2100) −24, −1, 19 4.30 1.00
Subclusters: Thalamus R 2938 (109) 11, −15, 7 4.21 .77
Thalamus L 2213 (82) −10, −16, 10 4.11 .84
Putamen R 280 (10) 25, −1, 0 3.68 .41
Putamen L 1475 (55) −22, 2, 6 4.28 .87
Insula L 544 (20) −26, 16, 9 4.12 .65
Hippocampus L 905 (34) −28, −34, 0 4.42 .94
Caudate L 1181 (44) −14, 15, 13 5.31 1.71
dlPFC L 13771 (510) −30, 27, 20 4.36 1.00
Anterior Cingulate L/R 794 (29) −7, 21, 22 3.76 .54
Frontal eye ﬁelds_dlPFC_posterior cingulate R 8789 (326) 17, 15, 28 4.23 1.00
Subcluster: Posterior cingulate R 409 (15) 4, −18, 33 4.17 .82
(D) Group X condition
Putamen_caudate_thalamus_orbital frontal cortex_ventral
striatum_anterior cingulate_insula_hypothalamus
26068 (965) −1, 1, 3 4.63 1.50
Subclusters: Putamen L 2918 (108) −24, 0, 4 5.17 1.90
Caudate 1364 (51) 14, 4, 13 4.04 .78
Caudate L 1449 (54) −13, 9, 7 4.45 1.04
Thalamus 1592 (59) 9, −15, 9 4.01 .70
Thalamus L 717 (27) −8, −17, 6 3.61 .42
Ventral Striatum 2004 (74) 10, 3, −2 5.43 1.93
Ventral Striatum L 1159 (43) −12, 1, −2 5.55 2.31
Medial Orbital Frontal Cortex L/R 474 (18) 10, 11, −14 4.37 .98
Lateral Orbital Frontal Cortex L/R 2299 (85) 24, 16, −10 4.43 1.04
Insula L 1208 (45) −33, −4, 13 4.45 .94
Note. All the main and interactive effects were detected with an uncorrected threshold of p< .05 and familywise error (FWE)-corrected with
c= 311 except the main effect of condition with an uncorrected threshold of p< .005 and c= 311 FWE-corrected. Brain regions starting with
“R” or “L” indicate right and left, respectively.
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condition (p= .0087 and .041, respectively) but not during
the other two conditions (Figure 1B).
Group-by-condition interaction
A group-by-condition interaction occurred in a ventral
striatal cluster extending to the medial and lateral orbito-
frontal cortex (OFC), thalamus, caudate, left insula, and
left putamen (Figure 1C and Table 2D). Relative to the HC
group, the PG group demonstrated signiﬁcantly greater
recruitment during the cocaine condition (p= .0098), less
activation during the sad condition (p= .031), and no differ-
ence during the gambling condition (p= .24; Figure 1D).
Main effects of DBH genotype
A main DBH-genotype effect demonstrated greater CC
group activity in the left VS extending to the OFC, ACC,
amygdala, caudate, putamen, and vmPFC (Table 2A
and Figure 2A), relative to the T-carriers (Figure 2B,
Cluster-a). Another cluster extended from the cerebellum
to the hippocampus and also displayed relatively greater
activity in the CC versus T-carrier groups (Figure 2B,
Cluster-b).
Main effects of condition
A main condition effect recruited the bilateral thalamus
extending to the posterior cingulate and appeared to be
driven by greater activation to the gambling versus cocaine
(p= 1.62 × 10−5) and gambling versus sad (p= .0067) con-
ditions, with no difference in the cocaine versus sad condi-
tion (p= .10) (Figure 2D, Cluster-c). Another cluster
extending from the vmPFC to the ACC and medial frontal
gyrus (Table 2B and Figure 2C) appeared to be driven
by decreased activation in the cocaine versus gambling
(p= .0021) and cocaine versus sad (p= .00094) conditions,
with no difference in the gambling versus sad conditions
(p= .57) (Figure 2D, Cluster-d).
Potential effects of outliers of BOLD-signal changes, as
depicted in Figures 1 and 2, were evaluated by exclusion
and retest; all the effects in the retests remained similar.
Main effects of DBH genotype and condition remained
strong. Effects of DBH-genotype-by-condition kept the
striatal cluster (p= .012) and the cluster with the posterior
cingulate cortex was in marginal signiﬁcance (p= .074), and
both appeared to be driven by the sad condition. Effects of
group-by-condition for the PG group relative to the HC
group demonstrated similar results, which reﬂected greater
Figure 2. Main effects of DBH genotype and condition. Axial brain sections highlighting regions showing signiﬁcant main effects of DBH
genotype (A) and condition (C) with age adjustment are shown. The maps are thresholded at p< .05, with a family-wise-error correction.
Talairach z of slices levels are indicated. The bar on the right side of the Figures A and C indicates the strengths of effects. Right side of the
brain is shown on the left. Indicated on the right are extracted values of percentage signal change according to (B) genotype (CC, T-carrier) or
(D) condition (gambling, sad, and cocaine). Outliers of BOLD-signal are marked by circles; outlier evaluation by exclusion and retest; all the
effects in the retests remained similar. Cluster-a: ventral striatum/orbital frontal cortex/anterior cingulate/rostrolateral prefrontal cortex/
inferior frontal gyrus/amygdala. Cluster-b: Cerebellum/parahippocampus/hippocampus/Fusiform. Cluster-c: Occipital cortex/temporal
gyrus/angular gyrus/fusiform gyrus/temporopolar area/thalamus/posteror cingulate/cerebellum. Cluster-d: Anterior cingulate cortex/anterior
prefrontal cortex/orbitofrontal gyri/insula
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recruitment during the cocaine condition (p= .016), less
recruitment during the sad condition (p= .09), and no
difference during the gambling condition (p> .4).
Subjective responses
The subjective response ratings to the videos, involving
ratings of emotional intensity, gambling urges, and drug
cravings, are summarized by comparisons of the diagnostic
groups (Table 3) and the genotype groups for the sad
condition (Table 1B). The T-carriers responded to the sad
videos with less subjective sadness (p= .035, Table 1B).
More detailed descriptions regarding the subjective
responses of the PG versus HC groups are presented in
Supplementary Material VII. In comparison to the T-
carriers, CC participants demonstrated stronger correlations
between brain activations and subjective emotional intensity
in response to the sad videos in a cluster extending from the
parietal cortex (including inferior parietal lobule) to the
inferior occipital gyrus (whole-brain correction p< .05;
Supplementary Material VII, Figure S3).
DISCUSSION
This ﬁrst study investigating DBH genetic inﬂuences on
brain activity found that the functional T allele in DBH SNP
rs1611115, which reduces the conversion of dopamine to
norepinephrine, corresponds with different BOLD-signal
changes in responses to gambling, drug or sad cues in
individuals with and without PG. A main effect of genotype
was observed with respect to responses to the videotapes in
the amygdala, vmPFC, and striatal areas, and a DBH-
genotype-by-condition, as well as group-by-condition inter-
actions, implicated corticostriatal-limbic regions. DBH ge-
notype was also linked to subjective responses to the sad
videotapes. The ﬁnding of DBH effects across diagnostic
groupings is consistent with transdiagnostic research efforts
(e.g., research domain criteria). Finally, cue-condition dif-
ferences were found in occipital and temporal cortices and
ventral prefrontal cortical regions. These ﬁndings, particu-
larly the novel DBH-related ﬁndings, suggest an important
role for dopamine and norepinephrine in subjective sadness
and brain correlates of emotional regulation, impulse con-
trol, and motivational processes.
Subjective responses
Subjective responses to the videos provide a validity check
(i.e., speciﬁcity of responsiveness as designed) and are
consistent with previous studies reporting stronger gambling-
urge responses during the gambling-cue condition in the PG
group (Potenza et al., 2003) and for cue-speciﬁcity as in the
larger sample (Kober et al., 2016). Interestingly, the PG
group also reported stronger gambling urges to the sad
and cocaine-cue conditions, suggesting that other states
(dysphoric, drug-cue-related) may trigger gambling urges;
alternatively, persistent baseline gambling urges may endure
across conditions in the PG group.
Main effect of DBH genotype
Collapsed across diagnostic groups and video conditions, the
increased recruitment by the CC relative to the T-carrier
subjects in dopaminergic projection sites suggests that greater
conversion of dopamine to norepinephrine may relate to
increased corticostriatal-limbic activation in regions implicat-
ed in emotional regulation, motivation, executive and cogni-
tive functions, and impulse control, among other processes
(Goldstein & Volkow, 2011; Li & Sinha, 2008; Satterthwaite
et al., 2007). Given the links between DBH activity and
addiction characteristics, manipulating the balance between
dopamine and norepinephrine could prove an effective treat-
ment strategy for multiple neuropsychiatric disorders
(Marecos, Ng, & Kurian, 2014). For example, the drug
disulﬁram is effective in the treatment of alcohol and CD,
possibly through effects on craving (Carroll et al., 2004;
Skinner et al., 2014). DBH inhibition by disulﬁram (Kosten
et al., 2013) may reduce craving via increasing dopamine
levels and decreasing norepinephrine levels (Carroll et al.,
2004). Accordingly, clinical case reports suggest that disulﬁ-
ram may reduce gambling urges in PG (Muller et al., 2011).
These reports provide a proof-of-principle for PG treatment
via DBH inhibition to regulate the balance between dopamine
and norepinephrine, which have both been implicated to
varying degrees in PG (Leeman & Potenza, 2012).
Table 3. Subjective responses to the tape viewing
Videotape condition Subjective responses PG mean [SD] HC mean [SD] PG versus HC p-values
Gambling Emotional intensity 7.89 [1.27] 4.78 [2.17] <.00001*
Gambling Gamble urge 7.53 [1.97] 1.16 [.40] <.00001*
Gambling Drugs urge 1.28 [.55] 1 [0] .046
Sad Emotional intensity 7.25 [2.01] 5.36 [1.93] .0038*
Sad Gamble urge 3.33 [2.66] 1 [0] .0017*
Sad Drugs urge 1.11 [.32] 1 [0] .163
Cocaine Emotional intensity 6.97 [2.38] 4.74 [2.18] .0034*
Cocaine Gamble urge 3.28 [2.71] 1.04 [.20] .0028*
Cocaine Drugs urge 1.94 [1.85] 1.08 [.28] .066
Note. Multiple comparison was adjusted by Bonferroni correction. The signiﬁcance threshold was set at .05/9= .00556 by taking into the
account that three subjective responses were tested for each of the three scenarios for each subject. SD= 0 reﬂected the same rating for all of
the responses in the subgroup analyzed.
*p< .00556.
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Subjective reports of greater sadness to sad videos were
reported in the CC group, relative to the T-carriers
(Table 1B), a ﬁnding that is consistent with reports of
lowered empathic characteristics in the T-carrier group
(Gong et al., 2014). Our results with fMRI extend these
ﬁndings to demonstrate diminished recruitment of frontos-
triatal circuitry in T-carriers, speciﬁcally during the sad
condition. These data link the DBH polymorphism with
alterations in frontostriatal responses while listening to
the personal distress of another person. Speciﬁcally, the
observed DBH-genotype-by-condition differences implicate
the dlPFC, midbrain, hippocampus, insula, caudate,
putamen, and thalamus. These brain regions are associated
with dopaminergic network differences in multiple addictive
behaviors and neuropsychiatric disorders (Leeman &
Potenza, 2012). The dlPFC is sensitive to levels of norepi-
nephrine and dopamine, in which imbalances may impair
prefrontal cortex function (Arnsten, 2011) and inﬂuence
emotional regulation (Perlstein, Elbert, & Stenger, 2002;
Urry et al., 2006). As the T allele is associated with
impulsivity, aggressive hostility, addiction vulnerability,
and altered noradrenergic function (Cubells et al., 2000;
Hess et al., 2009; Kalayasiri et al., 2007; Kohnke
et al., 2002), the diminished recruitment of corticostriatal
areas by T-carriers suggests possible neural substrates of
emotion dysregulation that may be conferred by the “risk”
T allele.
The identiﬁed brain areas, including left insula, caudate,
and putamen, are implicated in effort-based decision-
making (Treadway et al., 2012), preferences for rewarding
substances (Szczypka et al., 2001), and, arguably most
relevant to the current task, emotional regulation (Martinot
et al., 2001). Although small, the current sample demon-
strated numerically but not statistically higher impulsivity in
the T-carrier group (p< .10, Table 1B), consistent with
reports of a more impulsive personality style associated
with this genotype (Hess et al., 2009). Higher impulsivity
has been related to lower D2/D3 dopamine receptor avail-
ability in the midbrain (Buckholtz et al., 2010), with greater
amphetamine-related dopamine release related to mibrain
(substantia nigra) levels of D3 dopamine receptors in PG
subjects (Boileau et al., 2014). In PG, a disorder character-
ized by increased impulsivity, striatal dopamine D2/D3
receptor binding negatively correlates with mood-related
impulsivity (Clark et al., 2012). Future studies with larger
samples could examine potential interactions between
impulsivity, mood, and dopaminergic function in PG as
compared to non-PG samples.
Group effects across conditions
Group differences occurred in ventral PFC and ventral
striatal areas. Speciﬁcally, during the sad condition, the
PG group demonstrated diminished frontostriatal activity
and greater subjective sadness relative to the HC group
(Table 3). A previous study using the same task but an
independent sample demonstrated correlations between
sadness ratings and medial prefrontal regions in PG but not
HC subjects, suggesting differential sensitivities and altera-
tions in affective processing in PG (Balodis, Lacadie, &
Potenza, 2012). As impairments in emotional clarity and
awareness are noted in PG (Williams, Grisham, Erskine, &
Cassedy, 2012), further investigations could examine how
these activations relate to emotional dysregulation in PG.
The ﬁnding of relatively increased activity within this
cluster in the PG group to the cocaine-cue condition was
unanticipated and persisted after exclusion of the three
subjects with comorbid cocaine abuse/dependence. Further
research should examine the extent to which PG subjects’
responses to cocaine cues reﬂect predilections toward or
histories of cocaine use, particularly given the elevated
co-occurrence between PG and CD and genetic contribu-
tions to their co-occurrence (Xian et al., 2014).
Main effects of condition
The main effects of condition on brain activations, collapsed
across the DBH genotypes and the diagnostic groups, impli-
cated the OFC, vmPFC, anterior and posterior cingulate,
thalamus, caudate, left insula, andmedial frontal gyrus. Great-
er activation of occipital and temporal cortices, i.e., audio-
visual-processing regions, was observed during the gambling
condition. These ﬁndings complement those that have impli-
cated inPGpatient’s dorsal visual processing stream involving
the cuneus in motivational states underlying gambling urges
(Crockford, Goodyear, Edwards, Quickfall, & el-Guebaly,
2005), although the ﬁndings may also reﬂect qualities of the
gambling tape given the ﬁnding across diagnostic groups.
Future studies with larger samples may dissect effects of cue
conditions in individuals with different characteristics.
Main effect of diagnostic group
In contrast to our previous studies (Kober et al., 2016;
Potenza et al., 2003) using this task, the current study did
not detect a main effect of group on BOLD signal changes.
Sample characteristics and analytic technique differences
may underlie the discrepant ﬁndings. Our previous study
(Potenza et al., 2003) focused on male-only PG versus HC,
while the recent study (Kober et al., 2016) aimed at com-
paring neurobiological similarities and differences between
cocaine craving and gambling urges using both males and
females of multi-ethnic backgrounds in three diagnostic
groups of PG, CD, and HC individuals. These two previous
studies evaluated the ﬁrst and the last viewing periods, and
investigated between-group differences in neural activities
during viewing of videos of gambling, happy, or sad content
(Potenza et al., 2003), or with gambling, sad, and cocaine
content (Kober et al., 2016). The study (Potenza et al., 2003)
found that the most pronounced between-group differences
(PG versus HC) in neural activities were observed during
the initial period of viewing of the gambling conditions
(Potenza et al., 2003). In that study, PG subjects displayed
relatively decreased activity in frontal and OFC, caudate/
basal ganglia, and thalamus compared with controls. In our
recent study (Kober et al., 2016), a diagnostic group by
video interaction identiﬁed mPFC, which was activated
mainly to cocaine videos in CD participants during the
initial viewing period, and a more dorsal mPFC region that
was most strongly activated for cocaine videos in CD
participants, gambling videos in PG participants, and sad
videos in HC during the last viewing period. Our current
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study includes both men and women of EA-only PG versus
HC, and investigates signal changes during the entire period
of tape-viewing (a different analytic approach used in
[Potenza, 2008]). We have reanalyzed the current study
data separated by sex using the previous approaches, par-
tially replicating our previous ﬁndings in an independent
sample (Potenza et al., 2003) with relatively decreased
activities in VS (p= .033) of PG versus HC for the
male-only sample, but not for the vmPFC (see Supplemen-
tary Material X).
Strengths, limitations and future directions
Together, the ﬁndings suggest important roles for dopamine
and norepinephrine in emotion regulation and impulse
control and provide a context for the novel DBH-related
ﬁndings reported here. Strengths of this initial study lie in
the whole-brain analytic approach to assess neural activity
and sizable samples of CC and T-carrier subjects. While
some effects between cue conditions may linger, the coun-
terbalancing approach was designed to mitigate this possi-
bility. Responses to sad-scenario content (parental divorce, a
relative’s death) may differ based on individual subjects’
experiences; information regarding parental divorce or death
was not collected and limited us from evaluation of its
impact on the responses to sad cues. Nonetheless, the
qualitative and emotional intensity ratings by participants
provide support that the scenarios were successful in gen-
erating the intended emotional responses. Additionally,
ﬁndings in this study substantiate previous reports of
diminished empathy in T-carriers and extend these ﬁndings
to demonstrate the neural substrates underlying this effect.
Together with subjective reports, these ﬁndings therefore
provide proof-of-concept of the video task.
Small sample sizes when classifying by both diagnostic
group and DBH genotypes may have precluded identiﬁca-
tion of some signiﬁcant ﬁndings, such as the two-way and
three-way interaction effects of group-by-DBH-genotype
and group-by-DBH-genotype-by-condition, respectively.
Nonetheless, the sample sizes for main effects of DBH
genotype (N-CC= 20/N-T-carrier = 23) and condition (N=
43) and for two-way interactions of group-by-condition
(N-PG= 18/N-HC= 25) and DBH-genotype-by-condition
(N-CC= 20/N-T-carrier = 23) comply with recommended
guidelines for power and sample size consideration for
clinical fMRI studies (Carter, Heckers, Nichols, Pine, &
Strother, 2008). Additionally, some p values may not with-
stand correction for multiple comparisons (e.g., with respect
to allelic variation and subjective responses to sad videos).
Imbalances in co-occurring psychiatric disorders existed
between PG and HC groups; however, the PG pattern of
comorbidity is reﬂective of this clinical population (Barnes,
Welte, Tidwell, & Hoffman, 2015). After controlling for
comorbid conditions (i.e., cocaine and alcohol dependence),
results remained similar (see Supplementary Material VIII).
Further analyses contrasting smokers versus non-smokers
within the PG group found no difference between PG
smokers and PG non-smokers for the gambling and cocaine
scenarios but discovered some differences in the sad sce-
nario (see Supplementary Material IX). However, the brain
regions in response to the sad condition differ from the brain
regions, implicating corticostriatal-limbic neurocircuitry we
identiﬁed across the three conditions. Therefore, the differ-
ences between PG versus HC groups for the sad condition
do not appear attributable to smoking status.
Despite limitations, the current study identiﬁed DBH-
related differences in brain function in the processing of
affective and motivational cues in PG and HC groups. Given
DBH’s role in dopamine/norepinephrine balance, future
studies should investigate the extent to which targeting
dopamine and/or norepinephrine function in corticostriatal-
limbic brain regions might be helpful for PG treatment,
particularly in individuals with speciﬁc DBH allelic
identities.
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